ALV003

· Alvine Pharmaceuticals Inc.

Drug timelines are a Plus or Pro feature.

6 regulatory and trial events tracked for ALV003, covering 2009-06-11 to 2014-12-17. Get the full timeline:

Most recent: Clinical Trial Update: Evaluation of the Efficacy and Safety of ALV003 in Symptomatic in Celiac Disease Patients [Phase 2]